David Pearson
Overview
Explore the profile of David Pearson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
119
Citations
825
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bhargava D, Labadie A, Hanson-Rios-Stutz R, Goodyke A, Moses E, Das A, et al.
Physiol Genomics
. 2025 Mar;
PMID: 40073040
Defining physiology and methods to measure biological mechanisms is essential. Extensive datasets such as RNA sequencing are used with little analysis of the knowledge gained from the various methodologies. Within...
2.
Langlois J, Brenneisen S, Rodde S, Vangrevelinghe E, Rose G, Lerch P, et al.
J Med Chem
. 2024 Nov;
67(23):21163-21185.
PMID: 39576936
Osteoarthritis (OA) is a chronic and degenerative joint disease affecting more than 500 million patients worldwide with no disease-modifying treatment approved to date. Several publications report on the transforming growth...
3.
Judge L, Marsh J, Petersen J, Pearson D, Bellar D
J Strength Cond Res
. 2024 Oct;
38(12):2088-2098.
PMID: 39446733
Judge, LW, Marsh, JP, Petersen, JC, Pearson, D, and Bellar, D. Unveiling gaps in high school strength and conditioning: CSCS certification, coaching leadership and facilities. J Strength Cond Res 38(12):...
4.
Brandenburg C, Hilder J, Noble C, Liang R, Forrest K, Joshi H, et al.
BMC Med Educ
. 2024 Oct;
24(1):1200.
PMID: 39443892
No abstract available.
5.
Prokop J, Alberta S, Witteveen-Lane M, Pell S, Farag H, Bhargava D, et al.
Microorganisms
. 2024 Sep;
12(9).
PMID: 39338537
As of 2024, SARS-CoV-2 continues to propagate and drift as an endemic virus, impacting healthcare for years. The largest sequencing initiative for any species was initiated to combat the virus,...
6.
Brandenburg C, Hilder J, Noble C, Liang R, Forrest K, Joshi H, et al.
BMC Med Educ
. 2024 Sep;
24(1):1021.
PMID: 39294607
Background: Many medical trainees, prior to achieving specialist status, are required to complete a mandatory research project, the usefulness of which has been debated. The aim of this study was...
7.
Serven V, Swayampakala K, Lesassier C, Siekmann T, Rivera-Camacho G, Rao S, et al.
J Am Coll Emerg Physicians Open
. 2023 Oct;
4(5):e13047.
PMID: 37811361
Study Hypothesis: Our objective was to evaluate 30-day major adverse cardiac events (MACE) in emergency department (ED) patients with normal high-sensitivity troponins (hs-trop). We hypothesized that MACE rates would be ...
8.
Kattel P, Sulthana S, Trousil J, Shrestha D, Pearson D, Aryal S
ACS Omega
. 2023 Aug;
8(30):27146-27155.
PMID: 37546678
Biodegradable and biocompatible polymeric nanoparticles (NPs) stand out as a key tool for improving drug bioavailability, reducing the inherent toxicity, and targeting the intended site. Most importantly, the ease of...
9.
James A, Kulmatycki K, Poller B, Romeo A, Van Lier J, Klein K, et al.
Drug Metab Dispos
. 2023 Jun;
51(7):873-883.
PMID: 37308298
Iptacopan (LNP023) is an oral, small-molecule, first-in-class, highly potent proximal complement inhibitor that specifically binds factor B and inhibits the alternative complement pathway. Iptacopan is currently in development as a...
10.
Aloysius N, Ananda J, Mitsis A, Pearson D
Appetite
. 2023 Apr;
186:106577.
PMID: 37121486
Food waste is a significant global problem. In the Global North, households are a major driver of food waste generation and also a key enabler of solutions to address the...